2216 related articles for article (PubMed ID: 31649809)
1. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
2. De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.
Hamanaka K; Sugawara Y; Shimoji T; Nordtveit TI; Kato M; Nakashima M; Saitsu H; Suzuki T; Yamakawa K; Aukrust I; Houge G; Mitsuhashi S; Takata A; Iwama K; Alkanaq A; Fujita A; Imagawa E; Mizuguchi T; Miyake N; Miyatake S; Matsumoto N
Eur J Hum Genet; 2019 Mar; 27(3):378-383. PubMed ID: 30487643
[TBL] [Abstract][Full Text] [Related]
3. Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies.
Kim HG; Kim HT; Leach NT; Lan F; Ullmann R; Silahtaroglu A; Kurth I; Nowka A; Seong IS; Shen Y; Talkowski ME; Ruderfer D; Lee JH; Glotzbach C; Ha K; Kjaergaard S; Levin AV; Romeike BF; Kleefstra T; Bartsch O; Elsea SH; Jabs EW; MacDonald ME; Harris DJ; Quade BJ; Ropers HH; Shaffer LG; Kutsche K; Layman LC; Tommerup N; Kalscheuer VM; Shi Y; Morton CC; Kim CH; Gusella JF
Am J Hum Genet; 2012 Jul; 91(1):56-72. PubMed ID: 22770980
[TBL] [Abstract][Full Text] [Related]
4.
Butera A; Nicotera AG; Di Rosa G; Musumeci SA; Vitello GA; Musumeci A; Vinci M; Gloria A; Federico C; Saccone S; Calì F
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555772
[No Abstract] [Full Text] [Related]
5. A 137-kb deletion within the Potocki-Shaffer syndrome interval on chromosome 11p11.2 associated with developmental delay and hypotonia.
Montgomery ND; Turcott CM; Tepperberg JH; McDonald MT; Aylsworth AS
Am J Med Genet A; 2013 Jan; 161A(1):198-202. PubMed ID: 23239541
[TBL] [Abstract][Full Text] [Related]
6. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
7. Novel Pathogenic Variant (c.1171A>T) in
Lee C; Yoon J; Park BG; Eun BL; Kwon JA
Mol Syndromol; 2022 Jul; 13(4):318-322. PubMed ID: 36158052
[TBL] [Abstract][Full Text] [Related]
8. A novel de novo variant in the PHF21A causes craniofacial abnormalities, intellectual disability and skeletal manifestations.
Mustafa S; Abbas S; Mahmood A; Khan AZ; Zeb S; Khan A; Umair M
Clin Genet; 2023 Jul; 104(1):142-144. PubMed ID: 36843358
[TBL] [Abstract][Full Text] [Related]
9. A microdeletion encompassing PHF21A in an individual with global developmental delay and craniofacial anomalies.
Labonne JD; Vogt J; Reali L; Kong IK; Layman LC; Kim HG
Am J Med Genet A; 2015 Dec; 167A(12):3011-8. PubMed ID: 26333423
[TBL] [Abstract][Full Text] [Related]
10. Potocki-Shaffer syndrome in a child without intellectual disability-The role of PHF21A in cognitive function.
McCool C; Spinks-Franklin A; Noroski LM; Potocki L
Am J Med Genet A; 2017 Mar; 173(3):716-720. PubMed ID: 28127865
[TBL] [Abstract][Full Text] [Related]
11. TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletions.
Hijazi H; Reis LM; Pehlivan D; Bernstein JA; Muriello M; Syverson E; Bonner D; Estiar MA; Gan-Or Z; Rouleau GA; Lyulcheva E; Greenhalgh L; Tessarech M; Colin E; Guichet A; Bonneau D; van Jaarsveld RH; Lachmeijer AMA; Ruaud L; Levy J; Tabet AC; Ploski R; Rydzanicz M; Kępczyński Ł; Połatyńska K; Li Y; Fatih JM; Marafi D; Rosenfeld JA; Coban-Akdemir Z; Bi W; Gibbs RA; Hobson GM; Hunter JV; Carvalho CMB; Posey JE; Semina EV; Lupski JR
Am J Hum Genet; 2022 Dec; 109(12):2270-2282. PubMed ID: 36368327
[TBL] [Abstract][Full Text] [Related]
12. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
[TBL] [Abstract][Full Text] [Related]
13. Dual Molecular Effects of Dominant RORA Mutations Cause Two Variants of Syndromic Intellectual Disability with Either Autism or Cerebellar Ataxia.
Guissart C; Latypova X; Rollier P; Khan TN; Stamberger H; McWalter K; Cho MT; Kjaergaard S; Weckhuysen S; Lesca G; Besnard T; Õunap K; Schema L; Chiocchetti AG; McDonald M; de Bellescize J; Vincent M; Van Esch H; Sattler S; Forghani I; Thiffault I; Freitag CM; Barbouth DS; Cadieux-Dion M; Willaert R; Guillen Sacoto MJ; Safina NP; Dubourg C; Grote L; Carré W; Saunders C; Pajusalu S; Farrow E; Boland A; Karlowicz DH; Deleuze JF; Wojcik MH; Pressman R; Isidor B; Vogels A; Van Paesschen W; Al-Gazali L; Al Shamsi AM; Claustres M; Pujol A; Sanders SJ; Rivier F; Leboucq N; Cogné B; Sasorith S; Sanlaville D; Retterer K; Odent S; Katsanis N; Bézieau S; Koenig M; Davis EE; Pasquier L; Küry S
Am J Hum Genet; 2018 May; 102(5):744-759. PubMed ID: 29656859
[TBL] [Abstract][Full Text] [Related]
14. De novo variants in SETD1B are associated with intellectual disability, epilepsy and autism.
Hiraide T; Nakashima M; Yamoto K; Fukuda T; Kato M; Ikeda H; Sugie Y; Aoto K; Kaname T; Nakabayashi K; Ogata T; Matsumoto N; Saitsu H
Hum Genet; 2018 Jan; 137(1):95-104. PubMed ID: 29322246
[TBL] [Abstract][Full Text] [Related]
15. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
16. Haploinsufficiency of the Sin3/HDAC corepressor complex member SIN3B causes a syndromic intellectual disability/autism spectrum disorder.
Latypova X; Vincent M; Mollé A; Adebambo OA; Fourgeux C; Khan TN; Caro A; Rosello M; Orellana C; Niyazov D; Lederer D; Deprez M; Capri Y; Kannu P; Tabet AC; Levy J; Aten E; den Hollander N; Splitt M; Walia J; Immken LL; Stankiewicz P; McWalter K; Suchy S; Louie RJ; Bell S; Stevenson RE; Rousseau J; Willem C; Retiere C; Yang XJ; Campeau PM; Martinez F; Rosenfeld JA; Le Caignec C; Küry S; Mercier S; Moradkhani K; Conrad S; Besnard T; Cogné B; Katsanis N; Bézieau S; Poschmann J; Davis EE; Isidor B
Am J Hum Genet; 2021 May; 108(5):929-941. PubMed ID: 33811806
[TBL] [Abstract][Full Text] [Related]
17. De novo variants in PHF21A cause intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures: A case report and literature review.
Chen H; Chen Y; Wu H; Qiu X; Yu X; Wang R; Zhong J; Peng J
Seizure; 2023 Oct; 111():138-146. PubMed ID: 37633153
[TBL] [Abstract][Full Text] [Related]
18. [A case of intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures caused by PHF21A gene variation and review of literature].
Wu F; Ji XN; Shen MX; Gao YY; Zhang PP; Li SP; Chen Q
Zhonghua Er Ke Za Zhi; 2023 Aug; 61(8):726-730. PubMed ID: 37528014
[No Abstract] [Full Text] [Related]
19. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
[TBL] [Abstract][Full Text] [Related]
20. Targeted next generation sequencing of a panel of autism-related genes identifies an EHMT1 mutation in a Kleefstra syndrome patient with autism and normal intellectual performance.
Bock I; Németh K; Pentelényi K; Balicza P; Balázs A; Molnár MJ; Román V; Nagy J; Lévay G; Kobolák J; Dinnyés A
Gene; 2016 Dec; 595(2):131-141. PubMed ID: 27651234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
